## Abstract Studies in an inbred line of hamsters have revealed that animals bearing tumor transplants reject a second graft of the same cells. This resistance was specific and was manifested against tumor cells induced by viruses (PARA‐adenovirus 7, simian adenovirus 7) or chemicals (9,10‐dimethyl
Concomitant immunity in hamsters bearing dmba-induced tumor transplants
✍ Scribed by Robert N. Lausch; Fred Rapp
- Publisher
- John Wiley and Sons
- Year
- 1969
- Tongue
- French
- Weight
- 359 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Hamsters bearing progressively growing DMBA-induced tumor transplants were found to make a specific immune response to the. neoplasm. This response was identified because animals bearing DMBA tumors rejected conrentrations of DMBA-transformed cells that were capable of inducing tumors in normal animals. This concomitant immunity was detectable even when the immunizing and challenge cells were inoculated simultaneously. Animals bearing DMBA-induced tumor cell transplants were not protected against challenge with hamster cells transformed by simian papovavirus S V40, confirming the specificity of the concomitant immunity being studied.
📜 SIMILAR VOLUMES
## Abstract Induced antitumor immunity is a highly effective and long‐term cure for cancer, particularly for metastatic tumors. Laser immunotherapy was developed to induce such an immunologic response. It involves intratumoral administration of a light‐absorbing dye and a specially formulated immun
Only a small proportion of DMBA-induced rat mammary tumors are transplantable in cleared (gland-free) mammary fat pads. To enhance their transplantability, several host factors were modified: age, parity, hormone levels, and tissue integrity of the fat pad. Our 2 important findings were that (I) the
## Abstract We have previously shown that lymphocyte‐mediated immunity to common bladder tumor antigens can be demonstrated in vitro. In this study we used two carcinomas and two sarcomas of the urinary bladder of BALB/c mice to immunize syngeneic animals against tumor‐specific transplantation anti